ARTICLES BY THIS AUTHOR
- 8/22/2021
FDA approves first COVID-19 vaccine
Pfizer-BioNTech’s COVID-19 vaccine Comirnaty will be marketed for the prevention of COVID-19 in individuals age 16 years old and older. - 8/22/2021
Alembic launches generic Norpramin
Alembic's desipramine hydrochloride tablets provide a generic treatment for depression. - 8/22/2021
Lindholz, Anderson highlight industry’s accomplishments, opportunities at virtual NACDS Total Store Expo
NACDS' virtual Total Store Expo began Monday with a focus on all that pharmacies have accomplished amid COVID, as well as future challenges and opportunities. - 8/22/2021
FDA gives green light for Keytruda plus Lenvima combination
The FDA's approval of Keytruda plus Lenvima provides a first-line treatment of adult patients with advanced renal cell carcinoma, the company said. - 8/22/2021
Sam’s Club to offer codeSpark subscription
Sam’s Club members will receive member-only pricing and a 30 day free trial with their codeSpark Academy subscription. - 8/19/2021
Merck receives FDA nod for Welireg
Welireg is the first treatment for patients with von Hippel-Lindau disease, a genetic condition putting patients at risk of developing several cancers and other types of tumors. - 8/19/2021
Amazon reportedly to open department stores
Amazon is reportedly planning to open large retail locations that resemble department stores, according to a report from The Wall Street Journal. - 8/19/2021
NACDS makes recommendations to ensure COVID-19 booster shot access
In a letter to the Biden Administration, the organization conveyed recommendations to help ensure that eligible individuals can efficiently and effectively access additional COVID-19 doses at their local pharmacies. - 8/19/2021
Flu shots available at Walmart
Low-cost flu shots are now available in more than 4,600 Walmart pharmacies nationwide. - 8/18/2021
AAM calls for increased voluntary licensing of COVID vaccines to increase patient access
AAM noted that its members have worked hard to enhance patient access to affordable treatments, such as manufacturing dexamethasone, throughout the pandemic.